About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Neurosyphilis Presenting with Stroke and Complex Partial Seizure: Temporo-Parieto-Occipital Involvement
Ugur Kostakoglu1, Ayse Erturk1, Sevda Ozdemir Al1, Maksude Esra Kadioglu1, Mehmet Fatih Inecikli2, Ilknur Esen Yildiz1
1Department of Infectious Disease and Clinical Microbiology and 2Department of Radiology, Recep Tayyip Erdogan University, 53100, Rize, Turkey.
Corresponding Author:
Dr. Ayse Erturk
Email: ayseace25@hotmail.com
Received: 11-FEB-2019 Accepted: 13-JUN-2019 Published Online: 30-JUN-2019
DOI: http://dx.doi.org/10.17659/01.2019.0035
Abstract
Background: Syphilis is an infectious disease caused by Treponema pallidum with multiple organ involvement in which the central nervous system (CNS) is also affected. Neurosyphilis should be considered in the differential diagnosis of many CNS infections due to its numerous various clinical manifestations. Hemiparesia and complex partial seizures are rare presentations of syphilis. Case Report:  A 56 year old male patient was admitted to the emergency department due to fever, syncope and vomiting. His general condition was poor, he was somnolent and partially cooperative, and was disoriented in person and place. MRI resembled HSV encephalitis, mesial temporal syndromes; and increased mononuclear cells in cerebrospinal fluid (CSF) was suggestive for HSV encephalitis. However, CSF and blood tests supported the diagnosis of neurosyphilis. Conclusion: Neurosyphilis should not be overlooked at differential diagnosis in patients presenting with clinical and radiological findings suggestive of herpes encephalitis.
Keywords : Encephalitis, Neurosyphilis, Paresis, Seizures, Syphilis.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Dec 04, 2024